Randomised double-blind placebo-controlled trial protocol to evaluate the therapeutic efficacy of lyophilised faecal microbiota capsules amended with next-generation beneficial bacteria in individuals with metabolic dysfunction-associated steatohepatitis

Quinten J.J. Augustijn*, Aldo Grefhorst, Pleun De Groen, Koen Wortelboer, Jos F.M.L. Seegers, Ismail Sahin Gül, Peter Suenaert, Joanne Verheij, Willem M. De Vos, Hilde Herrema, Max Nieuwdorp, Adriaan G. Holleboom

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Randomised double-blind placebo-controlled trial protocol to evaluate the therapeutic efficacy of lyophilised faecal microbiota capsules amended with next-generation beneficial bacteria in individuals with metabolic dysfunction-associated steatohepatitis'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology